A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACERDA, Marcus Vinícius Guimarães e BARGIERI, Daniel Youssef. Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(21)00561-2. Acesso em: 17 nov. 2024. , 2022
APA
Lacerda, M. V. G., & Bargieri, D. Y. (2022). Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/S1473-3099(21)00561-2
NLM
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
Vancouver
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Paula Luize Camargos et al. Characterization of a novel mitovirus of the sand fly lutzomyia longipalpis using genomic and virus–host interaction signatures. Viruses, v. 13, n. 1, p. 20 , 2021Tradução . . Disponível em: https://doi.org/10.3390/v13010009. Acesso em: 17 nov. 2024.
APA
Fonseca, P. L. C., Ferreira, F., Silva, F. da, Kashiwabara, L. S. O., Marques, J. T., Goes Neto, A., et al. (2021). Characterization of a novel mitovirus of the sand fly lutzomyia longipalpis using genomic and virus–host interaction signatures. Viruses, 13( 1), 20 . doi:10.3390/v13010009
NLM
Fonseca PLC, Ferreira F, Silva F da, Kashiwabara LSO, Marques JT, Goes Neto A, Aguiar E, Gruber A. Characterization of a novel mitovirus of the sand fly lutzomyia longipalpis using genomic and virus–host interaction signatures [Internet]. Viruses. 2021 ; 13( 1): 20 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/v13010009
Vancouver
Fonseca PLC, Ferreira F, Silva F da, Kashiwabara LSO, Marques JT, Goes Neto A, Aguiar E, Gruber A. Characterization of a novel mitovirus of the sand fly lutzomyia longipalpis using genomic and virus–host interaction signatures [Internet]. Viruses. 2021 ; 13( 1): 20 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/v13010009
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Aléxia Adrianne Venceslau et al. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2021.102445. Acesso em: 17 nov. 2024.
APA
Carvalho, A. A. V., Favaro, M. T. de P., Pereira, L. R., Jesus, M. J. R., Pereira, S. S., Santos, R. A., et al. (2021). Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine. doi:10.1016/j.nano.2021.102445
NLM
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Vancouver
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRÜGER, Arne et al. Aptamer applications in emerging viral diseases. Pharmaceuticals, v. 14, n. 7, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14070622. Acesso em: 17 nov. 2024.
APA
Krüger, A., Santos, A. P. de J., Sá, V. K. de, Ulrich, H., & Wrenger, C. (2021). Aptamer applications in emerging viral diseases. Pharmaceuticals, 14( 7), 1-19. doi:10.3390/ph14070622
NLM
Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/ph14070622
Vancouver
Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/ph14070622
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lennon Ramos et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, v. 8, p. 19 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040565. Acesso em: 17 nov. 2024.
APA
Pereira, L. R., Vicentin, E. C. M., Pereira, S. A., Maeda, D. L. N. F., Alves, R. P. dos S., Santos, R. A., et al. (2020). Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, 8, 19 . doi:10.3390/vaccines8040565
NLM
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines8040565
Vancouver
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/vaccines8040565
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TZELEPIS, Fanny et al. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, v. 19, p. 240-252, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.omto.2020.10.007. Acesso em: 17 nov. 2024.
APA
Tzelepis, F., Birdi, H. K., Jirovec, A., Boscardin, S. B., Souza, C. T. de, Hooshyar, M., et al. (2020). Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, 19, 240-252. doi:10.1016/j.omto.2020.10.007
NLM
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
Vancouver
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Janaina Macedo da et al. Serum proteomics reveals alterations in protease activity, axon guidance, and visual phototransduction pathways in infants with in utero exposure to Zika Virus without congenital Zika syndrome. Frontiers in Cellular and Infection Microbiology, v. 10, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2020.577819. Acesso em: 17 nov. 2024.
APA
Silva, J. M. da, Fernandes, L. R., Barbosa, R. H., Pascale, C. B. A., Carvalho, F. R., Vianna, R. A. de O., et al. (2020). Serum proteomics reveals alterations in protease activity, axon guidance, and visual phototransduction pathways in infants with in utero exposure to Zika Virus without congenital Zika syndrome. Frontiers in Cellular and Infection Microbiology, 10, 16 . doi:10.3389/fcimb.2020.577819
NLM
Silva JM da, Fernandes LR, Barbosa RH, Pascale CBA, Carvalho FR, Vianna RA de O, Carvalho PC, Larsen MR, Cardoso CAA, Palmisano G. Serum proteomics reveals alterations in protease activity, axon guidance, and visual phototransduction pathways in infants with in utero exposure to Zika Virus without congenital Zika syndrome [Internet]. Frontiers in Cellular and Infection Microbiology. 2020 ; 10 16 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fcimb.2020.577819
Vancouver
Silva JM da, Fernandes LR, Barbosa RH, Pascale CBA, Carvalho FR, Vianna RA de O, Carvalho PC, Larsen MR, Cardoso CAA, Palmisano G. Serum proteomics reveals alterations in protease activity, axon guidance, and visual phototransduction pathways in infants with in utero exposure to Zika Virus without congenital Zika syndrome [Internet]. Frontiers in Cellular and Infection Microbiology. 2020 ; 10 16 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fcimb.2020.577819
; Bargieri, Daniel Youssef 
